Episode Details

Can GLP-1 medications like semaglutide and tirzepatide actually improve inflammatory skin diseases? Dermatologist Dr. Dray explores the emerging research connecting GLP-1 medications, weight loss, metabolic health, and inflammation, including what this could mean for psoriasis, psoriatic arthritis, and hidradenitis suppurativa (HS).

GLP-1 medications are best known for treating type 2 diabetes and obesity, but researchers are increasingly investigating their potential effects on inflammation. This video explains why adipose tissue can contribute to systemic inflammation, how GLP-1 signaling may influence inflammatory pathways, and whether improvements in skin disease can occur beyond the effects of weight loss.

Dr. Dray discusses the latest evidence, including the TOGETHER-PsO trial, which investigated tirzepatide in people with moderate-to-severe psoriasis and overweight or obesity, as well as emerging research on GLP-1 medications and hidradenitis suppurativa.

The video also covers:

• What GLP-1 medications are and how they work
• Semaglutide vs. tirzepatide
• Why obesity and inflammation are connected
• GLP-1 medications and psoriasis
• Tirzepatide and psoriasis clearance
• GLP-1 medications and psoriatic arthritis
• GLP-1 medications and hidradenitis suppurativa
• Whether GLP-1s have anti-inflammatory effects beyond weight loss
• Why metabolic health matters in inflammatory skin disease
• Whether everyone with psoriasis or HS should take a GLP-1
• Common GLP-1 side effects and risks
• Why GLP-1 medications require medical supervision
• What happens when GLP-1 medications are discontinued
• The potential future role of GLP-1 medications in dermatology

⏱️ TIMESTAMPS

0:00 Could GLP-1 medications help inflammatory skin disease?
1:03 What are GLP-1 medications?
1:47 Why would a weight-loss medication help a skin disease?
3:44 GLP-1s and psoriasis
5:33 What does this mean for psoriasis treatment?
6:34 GLP-1s and psoriatic arthritis
7:48 GLP-1s and hidradenitis suppurativa
10:43 Could the benefit be independent of weight loss?
12:26 Why does obesity matter so much in these diseases?
14:00 Should everyone with psoriasis or HS take a GLP-1?
14:30 What about side effects?
16:20 Start low and go slow
17:26 What happens if you stop?
17:44 Who should manage the GLP-1?
18:43 Where does this leave us?

RELATED VIDEOS

Can Skincare Fix Ozempic Face?
https://youtu.be/zURv_nMTUc0

Nutritional Deficiencies From GLP-1 Medications
https://youtu.be/SXjwBXIZtvQ

Ozempic Face and Aging Effects of GLP-1 Medications
https://youtu.be/E0V7jgubOfc

GLP-1s and Hair Loss
https://youtu.be/0VW43kd63zM

DISCLAIMER

This video is for educational and informational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. GLP-1 medications are prescription medications with potential benefits, side effects, contraindications, and risks. Anyone considering treatment should discuss whether a GLP-1 medication is appropriate with a qualified healthcare professional.

Dr. Dray's discussion of emerging research on GLP-1 medications and inflammatory skin disease does not mean that these medications are currently established treatments for psoriasis, psoriatic arthritis, or hidradenitis suppurativa in every patient.

#GLP1 #Ozempic #Wegovy #Mounjaro #Zepbound #Semaglutide #Tirzepatide #Psoriasis #HidradenitisSuppurativa #PsoriaticArthritis #Dermatologist #SkinHealth #Inflammation

FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links.

💜Shop my Amazon store

Listen Now